ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 73.01

Change

-0.18 (-0.25)%

Market Cap

CAD 0.28B

Volume

5.60K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-23 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.11 (-0.28%)

CAD 2.88B
ZWU:CA BMO Covered Call Utilities ETF

+0.07 (+0.58%)

CAD 1.93B
XHC:CA iShares Global Healthcare (CAD..

-0.20 (-0.26%)

CAD 0.66B
TXF:CA First Asset Tech Giants Covere..

-0.48 (-2.18%)

CAD 0.64B
XIT:CA iShares S&P/TSX Capped Informa..

+0.33 (+0.58%)

CAD 0.63B
HTA:CA Harvest Tech Achievers Growth ..

+0.02 (+0.11%)

CAD 0.62B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.20 (+0.90%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

+0.01 (+0.02%)

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.21 (+0.75%)

CAD 0.32B
COW:CA iShares Global Agriculture Com..

-0.08 (-0.13%)

CAD 0.28B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.04% 23% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.04% 20% F 34% F
Trailing 12 Months  
Capital Gain 12.37% 40% F 43% F
Dividend Return 0.78% 31% F 18% F
Total Return 13.15% 29% F 40% F
Trailing 5 Years  
Capital Gain 38.67% 40% F 65% D
Dividend Return 2.23% 16% F 9% A-
Total Return 40.90% 29% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 4.93% 31% F 55% F
Dividend Return 5.30% 26% F 52% F
Total Return 0.37% 28% F 26% F
Risk Return Profile  
Volatility (Standard Deviation) 16.66% 60% D- 50% F
Risk Adjusted Return 31.80% 29% F 51% F
Market Capitalization 0.28B 71% C- 50% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.